Court upholds advertising ban on Xenical in Australia
Pharma Compliance Alert, September 5, 2007
The Australian Federal Court upheld a ban on advertising for Roche's weight-loss drug Xenical.
A federal health committee in February banned Roche from advertising Xenical after complaints about the affect of the ads especially during the reality show Australian Idol. The Australian Consumers' Association said anecdotal evidence suggested girls as young as 13 in the healthy weight range were asking pharmacists for Xenical.
Roche appealed to the Federal Court, arguing the National Drugs and Poisons Schedule Committee had, in considering media coverage of Idol, breached its statutory limits. The court ruled the committee acted within its powers.
Roche will not appeal the decision.
Click here to read more.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched